MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing

50
14
Favorite

MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing

investorplace2021-04-25

MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（14）

DZJ1976
·2021-04-27
Back in the day, I was warned against spending all my money on weed and psychedelics. And yet, here we are! Good luck everyone...
Reply
Like
Report
无名之辈ET
·2021-04-25
Share
Reply
1
Report
russ1122
·2021-04-25
hi
Reply
2
Report
Kikiki
·2021-04-25
Cdff
Reply
4
Report
Fold Replies
- Ah_Chu:
  Nice
  2021-04-26
  Reply
  Report
- Ah_Chu:
  S
  2021-04-26
  Reply
  Report
- Kikiki:
  Uu
  2021-04-26
  Reply
  Report
View more 2 comments
banchin
·2021-04-25
Please respond my comments
Reply
Like
Report
Fredwkh
·2021-04-25
Like and comment pls
Reply
5
Report
Fold Replies
- yeun88:
  Pls comment bck
  2021-04-25
  Reply
  Report
- ponyinvestor:
  Leave a comment on my post in my profile pls
  2021-04-25
  Reply
  Report
- banchin:
  Hi, give me comments too
  2021-04-25
  Reply
  Report
boonhong21
·2021-04-25
Please like and comment [Smile] [Smile]
Reply
2
Report
Fold Replies
- Jher:
  Respond pls
  2021-04-25
  Reply
  Report
- heximania:
  ok
  2021-04-25
  Reply
  Report
- weijie123:
  help like and comment
  2021-04-25
  Reply
  Report
yeun88
·2021-04-25
Ok
Reply
2
Report
yeun88
·2021-04-25
Hi
Reply
Like
Report
Fold Replies
- banchin:
  Hi
  2021-04-25
  Reply
  Report
yeun88
·2021-04-25
Pls like & give me comment
Reply
1
Report
Fold Replies
- Pltretard:
  Done
  2021-04-25
  Reply
  Report
joycetan
·2021-04-25
?
Reply
3
Report
Fold Replies
- spin37gy:
  No comments
  2021-04-25
  Reply
  Report
Roystonchua
·2021-04-25
Cool
Reply
2
Report
Investingboy
·2021-04-25
I see
Reply
3
Report
yeun88
·2021-04-25
Pls give me a like & comment
Reply
1
Report
Fold Replies
- Zarkness:
  Ok sure 88
  2021-04-25
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1140669469?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-04-25 11:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140669469","market":"us","top_or_hot":-1,"title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","media":"investorplace","content":"<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","article_id":"1140669469","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","pubTimestamp":1619320559,"columns":[],"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"MMEDF股票：迷幻生物科技在纳斯达克上市前应注意的7件事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MMEDF":0.9},"content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":377321898,"gmtCreate":1619498472614,"gmtModify":1704724959468,"author":{"id":"3577722120895602","authorId":"3577722120895602","name":"DZJ1976","avatar":"https://static.tigerbbs.com/f0cb3bd8146604a31cbb6b27cf53752e","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3577722120895602","idStr":"3577722120895602"},"htmlText":"Back in the day, I was warned against spending all my money on weed and psychedelics. And yet, here we are! Good luck everyone...","listText":"Back in the day, I was warned against spending all my money on weed and psychedelics. And yet, here we are! Good luck everyone...","text":"Back in the day, I was warned against spending all my money on weed and psychedelics. And yet, here we are! Good luck everyone...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/377321898","repostId":1140669469,"repostType":2,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":375878475,"gmtCreate":1619327831397,"gmtModify":1704722523256,"author":{"id":"3581419193248011","authorId":"3581419193248011","name":"无名之辈ET","avatar":"https://static.tigerbbs.com/78a91672340fc997010d6993c8a2ab85","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3581419193248011","idStr":"3581419193248011"},"htmlText":"Share","listText":"Share","text":"Share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/375878475","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":375888767,"gmtCreate":1619322854359,"gmtModify":1704722454969,"author":{"id":"3566449916340164","authorId":"3566449916340164","name":"russ1122","avatar":"https://static.tigerbbs.com/410e5ecfb4da8e3f85caaaf9808925f2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3566449916340164","idStr":"3566449916340164"},"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/375888767","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":375881788,"gmtCreate":1619322727744,"gmtModify":1704722453676,"author":{"id":"3581229547024496","authorId":"3581229547024496","name":"Kikiki","avatar":"https://static.tigerbbs.com/f46fbae3962077a32ec82d426edd72ad","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581229547024496","idStr":"3581229547024496"},"htmlText":"Cdff","listText":"Cdff","text":"Cdff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/375881788","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4136255,"gmtCreate":1619419185198,"gmtModify":1680785641939,"authorId":3581301212987440,"author":{"id":3581301212987440,"idStr":"3581301212987440","authorId":3581301212987440,"name":"Ah_Chu","avatar":"https://static.tigerbbs.com/77910c9905bd274484b9bbec0e9f8d1d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375881788,"type":1,"supId":4128163,"prevId":0,"content":"Nice ","text":"Nice ","html":"Nice "},{"id":4136277,"gmtCreate":1619419459772,"gmtModify":1680785640378,"authorId":3581301212987440,"author":{"id":3581301212987440,"idStr":"3581301212987440","authorId":3581301212987440,"name":"Ah_Chu","avatar":"https://static.tigerbbs.com/77910c9905bd274484b9bbec0e9f8d1d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375881788,"type":1,"supId":0,"prevId":0,"content":"S","text":"S","html":"S"},{"id":4136253,"gmtCreate":1619419166420,"gmtModify":1680785639658,"authorId":3581229547024496,"author":{"id":3581229547024496,"idStr":"3581229547024496","authorId":3581229547024496,"name":"Kikiki","avatar":"https://static.tigerbbs.com/f46fbae3962077a32ec82d426edd72ad","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"80.51%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375881788,"type":1,"supId":4128163,"prevId":0,"content":"Uu","text":"Uu","html":"Uu"},{"id":4129106,"gmtCreate":1619343618496,"gmtModify":1680785527605,"authorId":3581229547024496,"author":{"id":3581229547024496,"idStr":"3581229547024496","authorId":3581229547024496,"name":"Kikiki","avatar":"https://static.tigerbbs.com/f46fbae3962077a32ec82d426edd72ad","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"80.51%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375881788,"type":1,"supId":0,"prevId":0,"content":"J","text":"J","html":"J"},{"id":4129104,"gmtCreate":1619343608833,"gmtModify":1680785527370,"authorId":3581229547024496,"author":{"id":3581229547024496,"idStr":"3581229547024496","authorId":3581229547024496,"name":"Kikiki","avatar":"https://static.tigerbbs.com/f46fbae3962077a32ec82d426edd72ad","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"80.51%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375881788,"type":1,"supId":4128169,"prevId":0,"content":"H","text":"H","html":"H"}],"langContent":"EN"},{"id":375818022,"gmtCreate":1619322050166,"gmtModify":1704722439403,"author":{"id":"3582063342503280","authorId":"3582063342503280","name":"banchin","avatar":"https://static.tigerbbs.com/5c4c72eded6f6ba8a8c66bbf3cd0e90c","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3582063342503280","idStr":"3582063342503280"},"htmlText":"Please respond my comments&nbsp;","listText":"Please respond my comments&nbsp;","text":"Please respond my comments","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/375818022","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":375819622,"gmtCreate":1619321941766,"gmtModify":1704722436640,"author":{"id":"3570424148942091","authorId":"3570424148942091","name":"Fredwkh","avatar":"https://static.tigerbbs.com/301d103aff8ff9955978aa630ee85588","vip":1,"crmLevel":7,"crmLevelSwitch":1,"authorIdStr":"3570424148942091","idStr":"3570424148942091"},"htmlText":"Like and comment pls&nbsp;","listText":"Like and comment pls&nbsp;","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/375819622","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4127550,"gmtCreate":1619327551696,"gmtModify":1680785494326,"authorId":3582013492527536,"author":{"id":3582013492527536,"idStr":"3582013492527536","authorId":3582013492527536,"name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375819622,"type":1,"supId":0,"prevId":0,"content":"Pls comment <u>bck</u>","text":"Pls comment <u>bck</u>","html":"Pls comment <u>bck</u>"},{"id":4126912,"gmtCreate":1619322485925,"gmtModify":1680785485823,"authorId":3575443999456708,"author":{"id":3575443999456708,"idStr":"3575443999456708","authorId":3575443999456708,"name":"ponyinvestor","avatar":"https://static.tigerbbs.com/138d1ebc8820019726a687f0ffe45994","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375819622,"type":1,"supId":0,"prevId":0,"content":"Leave a comment on my post in my profile pls","text":"Leave a comment on my post in my profile pls","html":"Leave a comment on my post in my profile pls"},{"id":4126823,"gmtCreate":1619322101257,"gmtModify":1680785482485,"authorId":3582063342503280,"author":{"id":3582063342503280,"idStr":"3582063342503280","authorId":3582063342503280,"name":"banchin","avatar":"https://static.tigerbbs.com/5c4c72eded6f6ba8a8c66bbf3cd0e90c","vip":1,"currentWearingBadge":{"badgeId":"23f878ed27704312ae41c7f17e73b319-2","templateUuid":"23f878ed27704312ae41c7f17e73b319","name":"Annualised return","description":"Top 30%","bigImgUrl":"https://community-static.tradeup.com/news/50461c8139b6ca50fe2dae19aa769b25","smallImgUrl":"https://community-static.tradeup.com/news/c8eef504853d5a517c50d7a88fa5c1e1","grayImgUrl":"https://community-static.tradeup.com/news/5273727845028b8d9b65556bdcb217b9","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.18","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":5300},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375819622,"type":1,"supId":0,"prevId":0,"content":"Hi, give me comments <u>too</u>","text":"Hi, give me comments <u>too</u>","html":"Hi, give me comments <u>too</u>"}],"langContent":"EN"},{"id":375897622,"gmtCreate":1619321281566,"gmtModify":1704722420181,"author":{"id":"3575147848250182","authorId":"3575147848250182","name":"boonhong21","avatar":"https://static.tigerbbs.com/4576487764c99ea59dfd1cfcdf89da5b","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3575147848250182","idStr":"3575147848250182"},"htmlText":"Please like and comment [Smile]&nbsp;[Smile]&nbsp;","listText":"Please like and comment [Smile]&nbsp;[Smile]&nbsp;","text":"Please like and comment [Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/375897622","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4126815,"gmtCreate":1619322069004,"gmtModify":1680785489438,"authorId":3571442481525664,"author":{"id":3571442481525664,"idStr":"3571442481525664","authorId":3571442481525664,"name":"Jher","avatar":"https://static.tigerbbs.com/f64e30965f55a5d41be6d9c44aa6535e","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.30","exceedPercentage":"80.60%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375897622,"type":1,"supId":0,"prevId":0,"content":"Respond pls","text":"Respond pls","html":"Respond pls"},{"id":4126664,"gmtCreate":1619321321075,"gmtModify":1680785483559,"authorId":3581984444466168,"author":{"id":3581984444466168,"idStr":"3581984444466168","authorId":3581984444466168,"name":"heximania","avatar":"https://static.tigerbbs.com/bd86363b09433494d0d0ca373221939c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375897622,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":4126719,"gmtCreate":1619321676522,"gmtModify":1680785483041,"authorId":3575205207637336,"author":{"id":3575205207637336,"idStr":"3575205207637336","authorId":3575205207637336,"name":"weijie123","avatar":"https://static.tigerbbs.com/f79451a0e5ae21cfbd9c59c760eed0a7","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.48%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375897622,"type":1,"supId":4126664,"prevId":0,"content":"help like and comment","text":"help like and comment","html":"help like and comment"}],"langContent":"EN"},{"id":375895252,"gmtCreate":1619321108276,"gmtModify":1704722417589,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3582013492527536","idStr":"3582013492527536"},"htmlText":"Ok&nbsp;","listText":"Ok&nbsp;","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/375895252","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":375892558,"gmtCreate":1619321063374,"gmtModify":1704722415643,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3582013492527536","idStr":"3582013492527536"},"htmlText":"Hi&nbsp;","listText":"Hi&nbsp;","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/375892558","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4126779,"gmtCreate":1619321901177,"gmtModify":1680785483227,"authorId":3582063342503280,"author":{"id":3582063342503280,"idStr":"3582063342503280","authorId":3582063342503280,"name":"banchin","avatar":"https://static.tigerbbs.com/5c4c72eded6f6ba8a8c66bbf3cd0e90c","vip":1,"currentWearingBadge":{"badgeId":"23f878ed27704312ae41c7f17e73b319-2","templateUuid":"23f878ed27704312ae41c7f17e73b319","name":"Annualised return","description":"Top 30%","bigImgUrl":"https://community-static.tradeup.com/news/50461c8139b6ca50fe2dae19aa769b25","smallImgUrl":"https://community-static.tradeup.com/news/c8eef504853d5a517c50d7a88fa5c1e1","grayImgUrl":"https://community-static.tradeup.com/news/5273727845028b8d9b65556bdcb217b9","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.18","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":5300},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375892558,"type":1,"supId":0,"prevId":0,"content":"<u>Hi</u>","text":"<u>Hi</u>","html":"<u>Hi</u>"}],"langContent":"EN"},{"id":375896723,"gmtCreate":1619321030262,"gmtModify":1704722415157,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3582013492527536","idStr":"3582013492527536"},"htmlText":"Pls like &amp; give me comment&nbsp;","listText":"Pls like &amp; give me comment&nbsp;","text":"Pls like & give me comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/375896723","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4126786,"gmtCreate":1619321944064,"gmtModify":1680785484098,"authorId":3575710348995261,"author":{"id":3575710348995261,"idStr":"3575710348995261","authorId":3575710348995261,"name":"Pltretard","avatar":"https://static.tigerbbs.com/20d7e9e6ca27ec0b458dcd81b8f9909f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375896723,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"EN"},{"id":375898708,"gmtCreate":1619320968704,"gmtModify":1704722413700,"author":{"id":"3581585492598201","authorId":"3581585492598201","name":"joycetan","avatar":"https://static.tigerbbs.com/2a617dc12b31a5ea9df17dcec57dbf7f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3581585492598201","idStr":"3581585492598201"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/375898708","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4126674,"gmtCreate":1619321418873,"gmtModify":1680785485886,"authorId":3574212983712096,"author":{"id":3574212983712096,"idStr":"3574212983712096","authorId":3574212983712096,"name":"spin37gy","avatar":"https://static.tigerbbs.com/97dfcecfb7a4ab4bcb3c2ae6bb551e51","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375898708,"type":1,"supId":0,"prevId":0,"content":"No comments","text":"No comments","html":"No comments"}],"langContent":"EN"},{"id":375898156,"gmtCreate":1619320918975,"gmtModify":1704722412729,"author":{"id":"3563277649917667","authorId":"3563277649917667","name":"Roystonchua","avatar":"https://static.itradeup.com/news/d590b748e178c97e704af00269043af7","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3563277649917667","idStr":"3563277649917667"},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/375898156","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":375898922,"gmtCreate":1619320913066,"gmtModify":1704722412568,"author":{"id":"3581591371008405","authorId":"3581591371008405","name":"Investingboy","avatar":"https://static.tigerbbs.com/cd4d390114a459f93e512ef6d9dc6fec","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3581591371008405","idStr":"3581591371008405"},"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/375898922","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":375891417,"gmtCreate":1619320898639,"gmtModify":1704722412074,"author":{"id":"3582013492527536","authorId":"3582013492527536","name":"yeun88","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3582013492527536","idStr":"3582013492527536"},"htmlText":"Pls give me a like &amp; comment&nbsp;","listText":"Pls give me a like &amp; comment&nbsp;","text":"Pls give me a like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/375891417","repostId":1140669469,"repostType":4,"repost":{"id":"1140669469","kind":"news","pubTimestamp":1619320559,"share":"https://ttm.financial/m/news/1140669469?lang=&edition=fundamental","pubTime":"2021-04-25 11:15","market":"us","language":"en","title":"MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1140669469","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock was getting high on Friday as the penny stock prepares for an uplisting to the<b>Nasdaq Exchange</b>from the<b>OTC Markets</b>.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1b4635c5b34c5363ffb97b340eb47273\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: luckakcul / Shutterstock.com</span></p><p>So when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.</p><ul><li>The changeover will take place on Tuesday.</li><li>This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.</li><li>The company will also continue to trade its shares on the<b>Neo Exchange</b>under the MMED stock ticker.</li><li>The NEO Exchange allows the stock to continue trading in Canada and Germany.</li><li>MindMed is a clinical-stage psychedelic medicine biotech company.</li><li>Its focus is on discovering, developing, and launching psychedelic-inspired medicines.</li><li>The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”</li></ul><p>J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.</p><blockquote>“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”</blockquote><p>MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.</p><p>MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.</p><p>MindMed might not be the only penny stock that investors want to keep track of.</p><p>While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into are<b>ION Geophysical Corporation</b>(NYSE:<b><u>IO</u></b>),<b>Asensus Surgical</b>(NYSEMKT:<b><u>ASXC</u></b>),<b>Citius Pharmaceuticals</b>&nbsp;(NASDAQ:<b><u>CTXR</u></b>), and others. You can get up to speed on the below.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMMEDF Stock: 7 Things to Know About Psychedelic Biotech MindMed Ahead of Its Nasdaq Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-25 11:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mmedf-stock-7-things-to-know-about-psychedelic-biotech-mindmed-ahead-of-its-nasdaq-listing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140669469","content_text":"MindMed(OTCMKTS:MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to theNasdaq Exchangefrom theOTC Markets.Source: luckakcul / Shutterstock.comSo when exactly can investors expect to see MMEDF stock uplist?All the details investors need to know are below.The changeover will take place on Tuesday.This will also have it switching away from its current ticker in favor of the new MNMD stock ticker.The company will also continue to trade its shares on theNeo Exchangeunder the MMED stock ticker.The NEO Exchange allows the stock to continue trading in Canada and Germany.MindMed is a clinical-stage psychedelic medicine biotech company.Its focus is on discovering, developing, and launching psychedelic-inspired medicines.The company’s pipeline includes treatments based on “Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC.”J.R. Rahn, co-founder and CEO of MindMed, had this to say about the news pushing MMEDF stock up today.“We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”MMEDF stock is seeing heavy trading on today’s uplist news. As of this writing, more than 8.7 million shares of the stock have changed hands. That’s an impressive increase over its daily average trading volume of 2.7 million shares.MMEDF stock was up 45.5% Friday afternoon but is only up 6.5% since the start of the year.MindMed might not be the only penny stock that investors want to keep track of.While it’s true that penny stocks are risky to invest in, it’s still worthwhile to keep an eye on them. Afterall, they might not all be penny stocks in the future. Some worth looking into areION Geophysical Corporation(NYSE:IO),Asensus Surgical(NYSEMKT:ASXC),Citius Pharmaceuticals (NASDAQ:CTXR), and others. You can get up to speed on the below.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4126784,"gmtCreate":1619321940527,"gmtModify":1680785485109,"authorId":3572916667219493,"author":{"id":3572916667219493,"idStr":"3572916667219493","authorId":3572916667219493,"name":"Zarkness","avatar":"https://static.tigerbbs.com/4b8c61830c4883c4232aece921d89d14","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.09","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":375891417,"type":1,"supId":0,"prevId":0,"content":"Ok sure 88","text":"Ok sure 88","html":"Ok sure 88"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":50,"commentSize":14,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}